Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1642 1677 1678
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17934950 | PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION | Final Rejection | KASHIV BIOSCIENCES, LLC |
| 19037543 | METHOD FOR DETERMINING AMOUNTS OF NAD METABOLITES FROM SAMPLE AND METHODS AND USES RELATED THERETO | Non-Final OA | HELSINGIN YLIOPISTO |
| 17901294 | SYSTEM AND SENSOR ARRAY | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 17442782 | BIOMARKER WITH THERAPEUTIC IMPLICATIONS FOR PERITONEAL CARCINOMATOSIS | Final Rejection | SINGAPORE HEALTH SERVICES PTE LTD |
| 17914282 | REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED | Non-Final OA | Denka Company Limited |
| 18473207 | PROTEIN SEQUENCING METHOD AND REAGENTS | Final Rejection | The Governing Council of the University of Toronto |
| 18256516 | Biomarkers for Detecting Cancer | Non-Final OA | University of Cape Town |
| 18153965 | VEGF and TIE2-Binding Fusion Protein and Uses Thereof | Non-Final OA | INGENIA Therapeutics Inc. |
| 18002114 | Methods For Identification of Cognate Pairs of Ligands and Receptors | Non-Final OA | HiFiBio (HK) Limited |
| 17921275 | BIOMARKERS FOR DETECTION OF LUNG CANCER | Non-Final OA | The Translational Genomics Research Institute (TGEN) |
| 17788632 | PROGNOSTIC BIOMARKER OF CANCER | Final Rejection | Yuko HASHIMOTO |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy